Loading compound...
Endothelin receptor antagonist
Darusenan is a small molecule currently being studied in clinical research (Phase 3). It works by blocking endothelin receptors (both ET-A and ET-B), which may help manage high blood pressure (hypertension).
How it worksDarusenan acts as an antagonist to endothelin receptors ET-A and ET-B, meaning it blocks these receptors from working.
Used for
Hypertension (high blood pressure)
Conditions
Hypertension
Class
Endothelin receptor antagonistCardiovascular
How to take
This drug is currently in Phase 3 clinical trials and is not yet a standard approved treatment for general use based on the provided data.
Talk to your doctor
Questions to ask
- ·Is Darusenan appropriate for my type of hypertension?
- ·What stage of clinical testing is Darusenan currently in?
- ·Are there any known interactions with my current medications?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.
